Maturational aspects of epilepsy mechanisms and consequences for the immature brain

Epilepsia

Volumn 42, Issue 5, 2001, Pages 577-585

  Sanchez, Russell M ^a   Jensen, Frances E ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANTICONVULSIVE AGENT; GLUTAMATE RECEPTOR; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; ION CHANNEL; IONOTROPIC RECEPTOR; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; VOLTAGE GATED CHANNEL FORMING PROTEIN;

AMINO ACID TRANSPORT; ANIMAL MODEL; ARTICLE; BRAIN DEVELOPMENT; BRAIN FUNCTION; EPILEPSY; EPILEPTIC STATE; INCIDENCE; NEUROMODULATION; PRIORITY JOURNAL; RECEPTOR DENSITY; SEIZURE; SYNAPTOGENESIS;

AGE FACTORS; AMINO ACID TRANSPORT SYSTEM X-AG; ANIMALS; ANTICONVULSANTS; ATP-BINDING CASSETTE TRANSPORTERS; BRAIN; CORTICOTROPIN-RELEASING HORMONE; DISEASE MODELS, ANIMAL; EPILEPSY; HUMANS; INFANT, NEWBORN; MICE; POTASSIUM CHANNELS; RATS; RECEPTORS, GABA; RECEPTORS, GLUTAMATE; STATUS EPILEPTICUS;

EID: 0035018620     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.2001.12000.x     Document Type: Article

References (119)

1. Holmes GL. Epilepsy in the developing brain: lessons from the laboratory and clinic. Epilepsia 1997;38:12-30.
2. Mizrahi EM, Kellaway P. Diagnosis and management of neonatal seizures. Philadelphia: Lippincott-Raven, 1998.
3. Volpe JJ. Neurology of the newborn. Philadelphia: WB Saunders, 1995:172-207.
4. Scher MS. Seizures in the newborn infant: diagnosis, treatment, and outcome. Clin Perinatol 1997;24:735-72.
5. Nehlig A, Motte J, Moshe SL, et al. Childhood epilepsies and brain development. London: John Libbey, 1999.
6. Pellock JM. Drug treatment in children. In: Engel J Jr, Pedley TA, eds. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott-Raven, 1997:1205-10.
7. Painter MJ, Scher MS, Stein AD, et al. Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N Engl J Med 1999;341:485-9.
8. Mattson RH. Selection of antiepileptic drug therapy. In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic drugs. New York: Raven Press, 1995:123-35.
9. Camfield P, Camfield C, Hirtz D. Treatment of febrile seizures. In: Engel J Jr, Pedley TA, eds. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott-Raven, 1997:1305-9.
10. Billard C. Anti-epileptic drugs and cognitive function. In: Nehlig A, Motte J, Moshe SL, Plouin P, eds. Childhood epilepsies and brain development. London: John Libbey, 1999:279-88.
11. Farwell JR, Lee YJ, Hirtz DG, et at. Phenobarbital for febrile seizures: effects on intelligence and on seizure recurrence. N Engl J Med 1990;322:364-9.
12. Sulzbacher S, Farwell JR, Temkin N, et al. Late cognitive effects of early treatment with phenobarbital. Clin Pediatr (Phila) 1999; 38:387-94.
13. Holmes GL, Lombroso CT. Prognostic value of background patterns in the neonatal EEG. J Clin Neurophysiol 1993;10:323-52.
14. Knudsen FU. Febrile seizures: treatment and prognosis. Epilepsia 2000;41:2-9.
15. Bergamasco B, Penna P, Ferrero P, et al. Neonatal hypoxia and epileptic risk: a clinical prospective study. Epilepsia 1984;25: 131-46.
16. Volpe JJ. Neonatal seizures. Pediatrics 1989;84:422-8.
17. Bernes SM, Kaplan AM. Evolution of neonatal seizures. Pediatr Clin North Am 1994;41:1069-104.
18. Rennie JM. Neonatal seizures. Ear J Pediatr 1997;156:83-7.
19. Cendes F. Early childhood prolonged febrile convulsions, atrophy and sclerosis of mesial structures, and temporal lobe epilepsy: an MRI volumetric study. Neurology 1993;43:1083-7.
20. French JA. Characteristics of medial temporal lobe epilepsy: I. Results of history and physical examination. Ann Neurol 1993; 34:774-80.
21. Abou-Khalil B, Andermann E, Andermann F. et al. Temporal lobe epilepsy after prolonged febrile convulsions: excellent outcome after surgical treatment. Epilepsia 1993;34:878-83.
22. Rocca WA, Sharbrough FW, Hauser WA, et al. Risk factors for complex-partial seizures: a population-based case control study. Ann Neurol 1987;21:22-31.
23. Van Landingham KE, Heinz ER, Cavazos JE, et al. Magnetic resonance imaging evidence of hippocampal injury after prolonged focal febrile convulsions. Ann Neurol 1998;43:413-26.
24. Berg AT, Shinnar S. Do seizures beget seizures? An assessment of the clinical evidence in humans. Clin Neurophysiol 1997;14: 102-10.
25. Annegers JF, Hauser WA, Shirts SB, et al. Factors prognostic of unprovoked seizures after febrile convulsions. N Engl J Med 1987;316:493-8.
26. Berg AT, Shinnar S, Levy SR, et al. Childhood-onset epilepsy with and without preceding febrile seizures. Neurology 1999;53: 1742-8.
27. Swann JW, Pierson MG, Smith KL, et al. Developmental neuro-plasticity: roles in early life seizures and chronic epilepsy. Adv Neurol 1999;79:203-16.
28. Fox K, Schlaggar BL, Glazewski S, et al. Glutamate receptor blockade at cortical synapses disrupts development of thalamo-cortical and columnar organization in somatosensory cortex. Proc Natl Acad Sci U S A 1996;93:5584-9.
29. Huttenlocher PR, deCourten C, Garey LJ, et al. Synaptogenesis in human visual cortex: evidence for synapse elimination during normal development. Neurosci Lett 1982;33:247-7.
30. Rakic P, Bourgeois JP, Eckenhoff MF, et al. Concurrent over-production of synapses in diverse regions of primate cortex. Science 1989;232:232-5.
31. Insel TR, Miller LP, Gelhard RE. The ontogeny of excitatory amino acid receptors in the rat forebrain. 1: N-methyl-D-aspartate and quisqualate receptors. Neuroscience 1990;35:31-43.
32. McDonald JW, Trescher WH, Johnston MV. Susceptibility of brain to AMPA induced excitotoxicity transiently peaks during early postnatal development. Brain Res 1992;583:54-70.
33. Romijn HJ, Hofman MA, Gramsbergen A. At what age is the developing cerebral cortex of the rat comparable to that of the full term newborn baby? Early Hum Dev 1991;26:61-7.
34. Dingledine R, Borges K, Bowie D, et al. The glutamate receptor ion channels. Pharmacol Rev 1999;51:7-61.
35. Conn PJ, Pin J-P. Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 1997;37:205-37.
36. Wong RK, Bianchi R, Taylor GW, et al. Role of metabotropic glutamate receptors in epilepsy. Adv Neurol 1999;79:685-98.
37. Aamodt SM, Constantine-Paton M. The role of neural activity in synaptic development and its implications for adult brain function. Adv Neurol 1999;79:133-44.
38. Vallano ML. Developmental aspects of NMDA receptor function. Crit Rev Neurobiol 1998;12:177-204.
39. Chapman AG. Glutamate receptors in epilepsy. Prog Brain Res 1998;116:371-83.
40. Michaelis EK. Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress, and aging. Prog Neurobiol 1998;54:369-415.
41. Meldrum BS. The role of glutamate in epilepsy and other CNS disorders. Neurology 1994;44(suppl 8):S14-23.
42. Miller LP, Johnson AE, Gelhard RE, et al. The ontogeny of excitatory amino acid receptors in the rat forebrain. II. Kainic acid receptors. Neuroscience 1990;35:45-51.
43. Johnston MV. Neurotransmitters and vulnerability of the developing brain. Brain Dev 1995;17:301-6.
44. Liu Z, Stafstrom CE, Sarkisian M, et al. Age-dependent effects of glutamate toxicity in the hippocampus. Brain Res Dev Brain Res 1996;97:178-84.
45. Young RS, Petroff OA, Aquila WJ, et al. Effects of glutamate, quisqualate, and N-methyl-D-aspartate in neonatal brain. Exp Neurol 1991;111:362-8.
46. Zhong J, Carrozza DP, Williams K, et al. Expression of mRNAs encoding subunits of the NMDA receptor in developing rat brain. J Neurochem 1995;64:531-9.
47. Monyer H, Burnashev N, Laurie DJ, et al. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 1994;12:529-10.
48. Flint AC, Maisch US, Weishaupt JH, et al. NR2A subunit expression shortens NMDA receptor synaptic currents in developing neocortex. J Neurosci 1997;17:2469-76.
49. 2+-permeable kainate/AMPA receptors more abundant in immature brain? Neurosci Lett 1992;144:65-9.
50. Burnashev N, Monyer H, Seehurg PH, et al. Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit. Neuron 1992;8:189-98.
51. 2+ permeability of AMPA-type glutamate receptor channels in neocortical neurons caused by differential expression of the GluR-B subunit. Neuron 1994;12:1281-9.
52. McBain CJ, Dingledine R. Heterogeneity of synaptic glutamate receptors on CA3 stratum radiatum interneurones of rat hippocampus. J Physiol 1993;462:373-92.
53. Washburn MS, Numberger M, Zhang S, et al. Differential dependence on GluR2 expression of the three characteristic features of AMPA receptors. J Neurosci 1997;17:9393-406.
54. Pellegrini-Giampietro DE, Bennett MVL, et al. Differential expression of three glutamate receptor genes in developing rat brain: an in situ hybridization study. Proc Natl Acad Sci U S A 1991; 88:4157-61.
55. Pellegrini-Giampietro DE, Gorter JA, Bennett MVL, et al. The GluR2 (GluR-B) hypothesis: Ca(2+)-permeable AMPA receptors in neurological disorders. Trends Neurosci 1997;20:464-70.
56. Friedman LK, Koudinov AR. Unilateral GluR2(B) hippocampal knockdown: a novel partial seizure model in the developing rat. J Neurosci 1999;19:9412-25.
57. Gerber U, Gahwiler BH. Modulation of ionic currents by metabotropic glutamate receptors. In: Conn PJ, Patel J, eds. The metabotropic glutamate receptors.Totowa, NJ: Humana Press, 1994: 125-46.
58. Glaum SR, Miller RJ. Acute regulation of synaptic transmission by metabotropic glutamate receptors. In: Conn PJ, Patel J, eds. The metabotropic glutamate receptors. Totowa, NJ: Humana Press, 1994:147-72.
59. Nicoletti E, Aronica E, Battaglia G, et al. Plasticity of metabotropic glutamate receptors in physiological and pathological conditions. In: Conn PJ, Patel J, eds. The metabotropic glutamate receptors. Totowa, NJ: Humana Press, 1994:243-69.
60. Casabona G, Genazzani AA, Di Stefano M, et al. Developmental changes in the modulation of cyclic AMP formation by the metabotropic glutamate receptor agonist 1S, 3R-aminocyclopentane-1,3-dicarboxylic acid in brain slices. J Neurochem 1992;59: 1161-3.
61. Schoepp DD, Johnson BG. Metabotropic glutamate receptor modulation of cAMP accumulation in the neonatal rat hippocampus. Neuropharmacology 1993;32:1359-65.
62. Schoepp DD, Johnson BG, Monn JA. (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid-induced increases in cyclic AMP formation in neonatal rat hippocampus are mediated by a synergistic interaction between phosphoinositide- and inhibitory cyclic AMP-coupled mGluRs. J Neurochem 1996;66:1981-5.
63. Meldrum BS, Akbar MT, Chapman AG. Glutamate receptors and transporters in genetic and acquired models of epilepsy. Epilepsy Res 1999;36:189-204.
64. Tanaka K, Watase K, Manabe T. et al. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 1997;276:1699-702.
65. Watanabe T, Morimoto K, Hirao T, et al. Amygdala-kindled and pentylenetetrazole-induced seizures in glutamate transporter GLAST-deficient mice. Brain Res 1999;845:92-6.
66. Furuta A, Rothstein JD, Martin LJ. Glutamate transporter subtypes are expressed differentially during rat CNS development. J Neurosci 1997;17:8363-75.
67. Sims KD, Robinson MB. Expression patterns and regulation of glutamate transporters in the developing and adult nervous system. Crit Rev Neurobiol 1999;13:169-97.
68. A receptor subunit mRNAs in the rat brain. III. Embryonic and postnatal development. J Neurosci 1992;12:4151-72.
69. Ben-Ari Y, Khazipov R, Leinekugel X, et al. GABA-A, NMDA, and AMPA receptors: a developmentally regulated "ménage à trois." Trends Neurosci 1997;20:523-9.
70. A receptors. Science 1995;269: 977-81.
71. - co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation. Nature 1999;397:251-5.
72. A-receptor subtypes in developing brain: actors or spectators? Perspect Dev Neurobiol 1998;5:179-92.
73. A receptors. Mol Neurobiol 1998;18:35-86.
74. Brooks-Kayal A, Jin H, Price M, et al. Developmental expression of GABA(A) receptor subunit mRNAs in individual hippocampal neurons in vitro and in vivo. J Neurochem 1998;70:1017-28.
75. A receptor-mediated miniature postsynaptic currents and α-subunit expression in developing cortical neurons. J Neurophysiol 1999;82: 3286-97.
76. A-receptor subtypes during postnatal development: an immunohistochemical study. J Neurosci 1994;14:5302-24.
77. Kapur J, Macdonald RL. Postnatal development of hippocampal dentate granule cell γ-aminobutyric acidA receptor pharmacological properties. Mol Pharmacol 1999;55:444-52.
78. Hollrigel GS, Soltesz I. Slow kinetics of miniature IPSCs during early postnatal development in granule cells of the dentate gyrus. J Neurosci 1997;17:5119-28.
79. B-mediated inhibition in the CA3 hippocampal region in the rat. J Neurobiol 1995;26:339-49.
80. B receptors in seizure suppression in developing rats. Brain Res Dev Brain Res 1994;79: 297-300.
81. Hosford DA, Lin F-H, Wang Y, et al. Studies of the lethargic (lh/lh) mouse model of absence seizures: regulatory mechanisms and identification of the lh gene. Adv Neurol 1999;79:239-52.
82. Snead OC III. Basic mechanisms of generalized absence seizures. Ann Neurol 1995;37:146-57.
83. B binding in rat brain. Neuroscience 1994;62:601-13.
84. Kubova H, Haugvicova R, Mares P. Moderate anticonvulsant action of baclofen does not change during development. Biol Neonate 1996;69:405-12.
85. Wasterlain CG, Mazarati AM. Neuromodulators and second messengers. In: Engel J Jr, Pedley TA, eds. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott-Raven, 1997:277-89.
86. Baram TZ, Hatalski CG. Neuropeptide-mediated excitability: a key triggering mechanism for seizure generation in the developing brain. Trends Neurosci 1998;21:471-6.
87. Baram TZ, Chalmers DT, Chen C, et al. The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor agonist. Brain Res 1997;770: 89-95.
88. Avishai-Eliner S, Yi SJ, Baram TZ. Developmental profile of messenger RNA for the corticotropin-releasing hormone receptor in the rat limbic system. Brain Res Dev Brain Res 1996;91:159-63.
89. Lee EY, Lee TS, Baik SH, et al. Postnatal development of somatostatin- and neuropeptide Y-immunoreactive neurons in rat cerebral cortex: a double-labeling immunohistochemical study. Int J Dev Neurosci 1998;16:63-72.
90. Burgunder JM. Ontogeny of somatostatin gene expression in rat forebrain. Brain Res Dev Brain Res 1994;78:109-22.
91. Moody WM. The development of voltage-gated ion channels and its relation to activity-dependent developmental events. Curr Top Dev Biol 1998;39:159-85.
92. Behrens MI, Latorre R. Potassium channels in developing excitable cells. In: Benos DJ, ed. Developmental biology of membrane transport systems: current topics in membranes. San Diego: Academic Press, 1991:327-55.
93. Jones SM, Ribera AB. Overexpression of a potassium channel gene perturbs neuronal differentiation. J Neurosci 1994;14:2789-99.
94. Smart SL, Lopantsev V, Zhang CL, et al. Deletion of the K(V)1.1 potassium channel causes epilepsy in mice. Neuron 1998;20:809-19.
95. Esplin MS, Abbott JR, Smart ML, et al. Voltage-sensitive calcium channel development in epileptic DBA/2J mice suggests altered presynaptic function. Epilepsia 1994;35:911-4.
96. Litzinger MJ, Grover B.B., Saderup S, et al. Voltage sensitive calcium channels mark a critical period in mouse neurodevelopment. Int J Dev Neurosci 1993;11:17-24.
97. Haglund MM, Schwartzkroin PA. Role of Na-K pump potassium regulation and IPSPs in seizures and spreading depression in immature rabbit hippocampal slices. J Neurophysiol 1990;63: 225-39.
98. Goodman JH, Wasterlain CG, Massarweh WF, et al. Calbindin-D28k immunoreactivity and selective vulnerability to ischemia in the dentate gyrus of the developing rat. Brain Res 1993;606:309-14.
99. Albala BJ, Moshe SL, Okada R. Kainic-acid-induced seizures: a developmental study. Brain Res 1984;315:139-48.
100. Stafstrom CE, Thompson JL, Holmes GL. Kainic acid seizures in the developing brain: status epilepticus and spontaneous recurrent seizures. Brain Res Dev Brain Res 1992;65:227-36.
101. Sperber EF. The relationship between seizures and damage in the maturing brain. Epilepsy Res 1996;S12:365-76.
102. Moshe SL, Albala BJ, Ackermann RF, et al. Increased seizure susceptibility of the immature brain. Brain Res 1983;283:81-5.
103. Dube C, Chen K, Eghbal-Ahmadi M, et al. Prolonged febrile seizures in the immature rat model enhance hippocampal excitability long term. Ann Neurol 2000;47:336-44.
104. Jensen FE, Wang C. Hypoxia-induced hyperexcitability in vivo and in vitro in the immature hippocampus. Epilepsy Res 1996; 26:131-40.
105. Chang D, Baram TZ. Status epilepticus results in reversible neuronal injury in infant rat hippocampus: novel use of a marker. Brain Res Dev Brain Res 1994;77:133-6.
106. Sperber EF, Haas KZ, Stanton PK, Moshe SL. Resistance of the immature hippocampus to seizure-induced synaptic reorganization. Brain Res Dev Brain Res 1991;60:88-93.
107. Nitecka L, Tremblay E, Charton G, et al. Maturation of kainic acid seizure-brain damage syndrome in the rat. II. Histopathological sequelae. Neuroscience 1984;13:1073-94.
108. Liu Z, Mikati M, Holmes GL. Mesial temporal sclerosis: pathogenesis and significance. Pediatr Neurol 1995;12:5-16.
109. Thompson K, Holm AM, Schousboue A, et al. Hippocampal stimulation produces neuronal death in the immature brain. Neuroscience 1998;82:337-48.
110. Sankar R, Shin DH, Liu H, et al. Patterns of status epilepticus-induced neuronal injury during development and long-term consequences. J Neurosci 1998;18:8382-93.
111. Wasterlain CG. Recurrent seizures in the developing brain are harmful. Epilepsia 1997;38:728-34.
112. Jensen FE, Holmes GH, Lombroso CT, et al. Age dependent long term changes in seizure susceptibility and neurobehavior following hypoxia in the rat. Epilepsia 1992;33:971-80.
113. Jensen FE, Wang C, Stafstrom CE, et al. Acute and chronic increases in excitability in rat hippocampal slices after perinatal hypoxia in vivo. J Neurophysiol 1998;79:73-81.
114. Jensen FE, Applegate CD, Holtzman D, et al. Epileptogenic effects of hypoxia in immature rodent brain. Ann Neurol 1991;29: 629-37.
115. Chen K, Baram TZ, Soltesz I. Febrile seizures in the developing brain result in persistent modification of neuronal excitability in limbic circuits. Nat Med 1999;5:888-94.
116. Anderson AE, Hrachovy RA, Swann JW. Increased susceptibility to tetanus toxin-induced seizures in immature rats. Epilepsy Res 1997;26:433-42.
117. Anderson AE, Hrachovy RA, Antalffy BA, et al. A chronic focal epilepsy with mossy fiber sprouting follows recurrent seizures induced by intrahippocampal tetanus toxin injection in infant rats. Neuroscience 1999;92:73-82.
118. Huang L, Cilio MR, Silveira DC, et al. Long-term effects of neonatal seizures: a behavioral, electrophysiological, and histological study. Brain Res Dev Brain Res 1999;118:99-107.
119. Holmes GL, Sarkisian M, Ben-Ari Y, et al. Mossy fiber sprouting after recurrent seizures during early development in rats. J Comp Neurol 1999;404:537-53.